Portfolio Lab

Hims & Hers Health, Inc.

  • Stock
  • Ticker HIMS
  • ISIN US4330001060
  • NYSE

Health care · Health care services · USA

$14.60 −8.86%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Hims & Hers Health, Inc. since 09/2019, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

HIMSGlobal equities (VT)

$10,000 grew to $18,718. Global equities (VT): $14,653.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −87.3% in 05/2022, measured from the peak in 02/2021. It took 40 months to get back to the old peak.

1-year return
−56.6%
5-year return p.a.
+14.8%
Return p.a. since 09/2019
+5.7%
Volatility p.a.
85.8%
Largest decline
−87.3%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue481586545599618608753890
Gross profit370431416442444397481509
Operating income195827129.2-78-97-66
EBITDA2566372927-56-68-28
Net income2649431621-92-86-33
Earnings per share0.100.200.170.060.08-0.40-0.37-0.14
Balance sheet
Total assets7088921,8782,2332,1552,2673,6293,547
Liabilities2313421,3151,6521,6141,8213,3053,192
Equity477549563581541446324355
Cash2212741,125346229222610606
Cash flow
Operating cash flow86109-191496189-3665
Capital expenditure-27-59-50-69-64-36-32-39
Free cash flow5950-7079-2.653-6826

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2024 at +171.7%, weakest 2021 at −55.1%. 4 of 6 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
9 Nov 2026−$0.14
10 Aug 2026−$0.37
11 May 2026−$0.40
23 Feb 2026$0.08
3 Nov 2025$0.06
4 Aug 2025$0.17
5 May 2025$0.20
24 Feb 2025$0.10
4 Nov 2024$0.32
5 Aug 2024$0.06
6 May 2024$0.05
26 Feb 2024$0.01

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€3.1bn
Market cap in trading currency
$3.41bn
Enterprise value
$2.70bn
P/E
–
P/S
1.19
P/B
9.61
EV/Sales
0.94
EV/EBITDA
–
Earnings yield
–
FCF yield
0.2%

Results (last four quarters)

Revenue
$2.87bn
Gross profit
$1.83bn
EBITDA
−$125m
Net income
−$191m
Earnings per share
−$0.83
Revenue per share
$12.27
Revenue growth
+48.6%
Earnings growth
−309.5%

Profitability

Gross margin
63.8%
Operating margin
-8.1%
Net margin
-6.7%
Return on equity
-40.8%
Return on assets
-5.4%

Balance sheet and cash flow

Cash
$712m
Cash per share
$3.05
Financial debt
–
Debt/equity %
–
Current ratio
0.92
Book value per share
$1.52
Operating cash flow
$180m
Free cash flow
$8.22m

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
–
Ex-dividend date
–

Shares and trading

Shares outstanding
234m
Volume
15.9m
Avg. volume 3 months
12.1m
Relative volume
1.3

Price and technicals

Price
$14.60
1 day
−8.9%
52-week high
$40.02
52-week low
$14.52
Distance to 52-week high
−63.5%
Distance to 52-week low
+0.6%
Distance to 50-day line
−44.9%
Distance to 200-day line
−44.8%
RSI (14)
25
Volatility 1M
108.1%

Performance

1 week
−26.0%
1 month
−49.9%
3 months
−53.0%
6 months
−38.5%
YTD
−55.0%
1 year
−59.3%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has HIMS performed since 09/2019?

$10,000 grew to $14,898 by 20 Nov 2026, which is +5.7% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is HIMS?

Volatility was 85.8% per year, measured on monthly returns. The largest decline from a peak was −87.3%, with the low in 05/2022.

How does HIMS compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 16.4% volatility, HIMS returned +5.7% at 85.8%. The correlation of monthly returns was 0.32; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Hims & Hers Health, Inc. (HIMS): Return and risk